Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2809 of 5804
-
New antibody combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis is a phase 1/2, open-label, multi-center, first-in-human, two-stage (Part 1: dose escalation and Part 2: dose expansion) study evaluating multiple doses and schedules of intravenously (IV) administered HMBD-002, with or without pembrolizumab KEYTRUDA®, in patients with advan…
Phase: PHASE1 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Fish oil pills could boost mood and memory, small study finds
Symptom relief CompletedThis study looked at whether taking omega-3 supplements can help reduce stress, anxiety, depression, and improve memory and sleep quality in Saudi adults who feel highly stressed or anxious. Omega-3 is a healthy fat found in fish oil that may help the brain and mood. A total of …
Phase: NA • Sponsor: Umm Al-Qura University • Aim: Symptom relief
Last updated Jun 26, 2026 14:05 UTC
-
New program aims to ease tough transition for teens with Crohn's
Disease control OngoingBackground: Transition in care is defined as the "purposeful and planned movement of adolescents and young adults with a chronic medical condition from pediatric to adult-oriented healthcare systems/care providers." Currently, there is no Level 1 evidence of an intervention to im…
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Lung cancer gene map after drug failure could guide next steps
Knowledge-focused CompletedAlthough some small sample studies have reported the possible resistance mechanisms of Osimertinib in the first-line treatment, it is still an urgent need to explore the whole gene profile in EGFRm advanced NSCLC patients post Osimertinib 1L treatment by paired tissue and plasma …
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:56 UTC
-
Vitamin B3 pill may shield CLL patients from skin cancer
Disease control Recruiting nowThis is a randomized, phase II, double-blind, placebo-controlled trial with planned crossover to the intervention arm after 1 year. Consenting patients with CLL who have had at least one NMSC diagnosed in the past year will be randomized to receive either oral nicotinamide 500 m…
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Hot flashes linked to heart risk? mayo clinic investigates
Knowledge-focused Recruiting nowWomen who experience hot flashes are at greater risk for hypertension and other cardiovascular disease. Neurovascular control mechanisms are likely to play an important role in this relationship. As such, these studies are designed to provide a major step forward in understanding…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Prehab before liver transplant: a new hope for frail patients?
Disease control CompletedThis study will assess the feasibility, safety and effectiveness of a structured prehabilitation program combining exercise training, nutritional optimization and psychological support for patients with cirrhosis awaiting liver transplantation.
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Phone tools help young thai men stick with HIV prevention
Prevention CompletedThe goal of this study is to develop and pilot test technology-based interventions to promote Pre-exposure Prophylaxis (PrEP) uptake and adherence among Thai young men who have sex with men (YMSM).
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
New procedure aims to help men with prostate cancer pee easier
Symptom relief OngoingThis is a Phase II prospective clinical trial in which patients with prostate carcinoma and obstructive lower urinary tract symptoms electing for radiation therapy will undergo Prostatic Artery Embolization (PAE) prior to treatment. PAE will be administered by Interventional Radi…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New study tests antifungal drug in infants to fight dangerous infections
Disease control Recruiting nowThis study aims to estimate the pharmacokinetics (PK) of posaconazole (POS, MK-5592) intravenous (IV) and powder for oral suspension (PFS) formulations in pediatric participants \<2 years of age with invasive fungal infection (IFI).
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 26, 2026 18:13 UTC
-
Finger-Prick test aims to uncover hidden hepatitis c cases
Knowledge-focused Recruiting nowThe National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing serv…
Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Spirulina-Based drug shows promise against food poisoning
Disease control CompletedRandomized, double-blind, placebo-controlled, single dose regimen study of LMN-101 followed by Campylobacter jejuni challenge. Subjects will initially, after documentation of informed consent, begin taking their assigned LMN-101 or placebo regimen three times daily. After two day…
Phase: PHASE2 • Sponsor: Lumen Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can yoga replace pills? new study tests yoga for chronic pain in opioid patients
Symptom relief CompletedPhase 2 - Multiphase Optimization Strategy (MOST) Optimization Phase: 1. To conduct a factorial experiment that will allow us to evaluate the impact of each of the 4 intervention components on yoga dosage received. We will enroll a total n=192. All participants will receive the …
Phase: NA • Sponsor: Butler Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Soak away diabetes risks? study tests hot foot baths for better blood sugar
Symptom relief Recruiting nowInsulin resistance and hyperglycemia predispose individuals with type 2 diabetes mellitus (T2DM) to endothelial dysfunction and a greater risk of cardiovascular diseases (CVD). Increased CVD risk in individuals with T2DM persists despite optimal pharmacological therapy, highlight…
Phase: NA • Sponsor: Montreal Heart Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Gene hunt: can DNA predict brain bleed risk?
Knowledge-focused Recruiting nowCerebral and medullary arteriovenous malformations (AVMs) lead to arterial and venous networks to communicate pathologically, creating an arteriovenous shunt. The occurrence of intracranial haemorrhage is the most important prognostic factor of AVMs because it is associated with …
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Battlefield burn study tests plasma vs albumin for better recovery
Disease control CompletedThe investigators propose a prospective randomized trial to study fresh frozen plasma (FFP) versus albumin to determine the optimal colloid in burn resuscitations. This work addresses both FY20 focus areas, prolonged field care (PFC) and en route care, along with mitigating secon…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Painkiller methadone joins chemo in fight against hard-to-treat colon cancer
Disease control OngoingThis is a phase I/II-trial with D,L-methadone and mFOLFOX6 in the treatment of patients with histologically confirmed chemo-refractory colorectal carcinoma. The aim of the phase-I trial is to evaluate the toxicity-profile and the dose-limiting toxicity of D,L-methadone combined …
Phase: PHASE1, PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Psoriasis 'Memory' targeted in new skin study
Knowledge-focused OngoingPsoriasis is a non-communicable chronic immune-mediated disease. Psoriatic skin is characterized by excessive proliferation of skin cells and infiltration of immune cells. The cause of psoriasis is so far unknown. Established therapeutics include topical, oral-systemic, biologic…
Phase: PHASE4 • Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Exercise program improves posture and balance in teens with rounded back
Symptom relief CompletedThis study was planned to investigate the effect of holistic approach corrective exercise program on the degree of kyphosis, balance and quality of life in kyphotic adolescents. A holistic approach corrective exercise program including corrective exercises and postural perception…
Phase: NA • Sponsor: Gaziantep Islam Science and Technology University • Aim: Symptom relief
Last updated Jun 26, 2026 13:20 UTC
-
Blood test may spot lingering lung cancer after surgery
Knowledge-focused CompletedPrognosis of resectable early stages NSCLC might be improved by a better knowledge of post-operative minimal residual disease (MRD). This could be achieved by studying patient with stage I to IIIA completely resected-NSCLC, comparing qualitative and quantitative features of pre- …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC